91
Participants
Start Date
June 28, 2017
Primary Completion Date
February 28, 2019
Study Completion Date
July 27, 2020
E2007
Oral tablet
Eisai Trial Site #18, Aichi
Eisai Trial Site #19, Aichi
Eisai Trial Site #11, Fukuoka
Eisai Trial Site #29, Fukuoka
Eisai Trial Site #4, Hiroshima
Eisai Trial Site #16, Hokkaido
Eisai Trial Site #8, Hokkaido
Eisai Trial Site #14, Hyōgo
Eisai Trial Site #6, Hyōgo
Eisai Trial Site #7, Kagoshima
Eisai Trial Site #9, Kanagawa
Eisai Trial Site #10, Kyoto
Eisai Trial Site #30, Miyagi
Eisai Trial Site #25, Nagasaki
Eisai Trial Site #27, Nagasaki
Eisai Trial Site #15, Nara
Eisai Trial Site #12, Niigata
Eisai Trial Site #21, Osaka
Eisai Trial Site #24, Osaka
Eisai Trial Site #26, Osaka
Eisai Trial Site #3, Saitama
Eisai Trial Site #5, Saitama
Eisai Trial Site #1, Shizuoka
Eisai Trial Site #22, Tochigi
Eisai Trial Site #28, Tokushima
Eisai Trial Site #20, Tokyo
Eisai Trial Site #23, Tokyo
Eisai Trial Site #31, Tokyo
Eisai Trial Site #13, Yamagata
Eisai Trial Site #17, Yamaguchi
Eisai Trial Site #32, Yamaguchi
Eisai Trial Site #38, Gyeonggi-do
Eisai Trial Site #36, Incheon
Eisai Trial Site # 2, Seoul
Eisai Trial Site #33, Seoul
Eisai Trial Site #34, Seoul
Eisai Trial Site #35, Seoul
Eisai Trial Site #37, Seoul
Eisai Co., Ltd.
INDUSTRY